Peter Thiel-backed psychedelic start-up's shares pop in Wall Street debut

The German biotech's initial public offering was priced Thursday night at $15 per share, the high end of the expected range.

from Health and Science https://ift.tt/35B6jSQ
https://ift.tt/eA8V8J
https://ift.tt/2zIUzyH